<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>
<channel>
	<title>Comments on: The Ins and Outs of Clinical Research Studies</title>
	<atom:link href="http://holycrossheartresearchblog.com/?feed=rss2&#038;p=453" rel="self" type="application/rss+xml" />
	<link>http://holycrossheartresearchblog.com/?p=453</link>
	<description>Just another WordPress weblog</description>
	<pubDate>Mon, 06 Sep 2010 01:48:38 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7.1</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Marilyn Mann</title>
		<link>http://holycrossheartresearchblog.com/?p=453&#038;cpage=1#comment-208</link>
		<dc:creator>Marilyn Mann</dc:creator>
		<pubDate>Fri, 04 Dec 2009 21:27:35 +0000</pubDate>
		<guid isPermaLink="false">http://holycrossheartresearchblog.com/?p=453#comment-208</guid>
		<description>I'm enjoying your blog, Dr. Niederman.  You mean ezetimibe, not ezetimide.  

I am familiar with the drug because my teenage daughter, who has heterozygous FH, was on it at one point -- until I found out that there were no studies showing that ezetimibe reduces the risk of heart attacks.  She's now on atorvastatin.</description>
		<content:encoded><![CDATA[<p>I&#8217;m enjoying your blog, Dr. Niederman.  You mean ezetimibe, not ezetimide.  </p>
<p>I am familiar with the drug because my teenage daughter, who has heterozygous FH, was on it at one point &#8212; until I found out that there were no studies showing that ezetimibe reduces the risk of heart attacks.  She&#8217;s now on atorvastatin.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
